Workshop on site and histology - Independent indications in oncology

14/12/2017 to 15/12/2017
Location: European Medicines Agency, London, UK
Biological drivers that define cancer course across anatomical sites and histologies offer an opportunity to select populations sensitive to specific drugs based on those drivers, independently of the specific site or histology. This workshop aims to provide an exchange of views from different stakeholders about situations where a site and histology-independent clinical development might be a viable option and the associated challenges in terms of drug development, benefit-risk evaluation and health-technology assessment.




To view the broadcast, please ensure that Adobe Flash Player is installed.

Note that you should see the live broadcast or the message 'We are currently not broadcasting' below, on this page. If the area below is black or in case of difficulties viewing the broadcast, please try connecting directly to our Ustream channel: European Medicines Agency or try viewing from an unrestricted connection, for example over wifi or 3G. For technical information about the required network security settings, please see this Ustream help page.

We recommend to press the 'HD' symbol on the player and select the option '720' to obtain the best quality of the video. For further assistance, please consult the Ustream Help Center

How useful was this page?

Add your rating